Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 40,000 | 16,000 | N/A | 142,593 | 105,825 |
| Depreciation Amortization | 12,000 | 6,000 | N/A | 8,291 | 4,811 |
| Income taxes - deferred | 1,900 | 2,700 | N/A | 1,827 | -1,826 |
| Accounts receivable | -13,900 | -1,500 | N/A | -17,307 | -11,597 |
| Accounts payable and accrued liabilities | -6,200 | 2,600 | N/A | -5,635 | -536 |
| Other Working Capital | -25,300 | -30,400 | N/A | -49,431 | -7,079 |
| Other Operating Activity | 51,100 | 11,600 | 0 | 68,942 | 48,433 |
| Operating Cash Flow | $59,600 | $7,000 | $N/A | $149,280 | $138,031 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,500 | -11,500 | N/A | -9,653 | -8,098 |
| Net Acquisitions | N/A | N/A | N/A | -223,531 | N/A |
| Purchase Of Investment | -22,600 | -5,900 | N/A | -105,451 | -102,661 |
| Sale Of Investment | 80,500 | 67,600 | N/A | 339,865 | 113,032 |
| Other Investing Activity | -21,600 | -22,700 | 0 | 0 | 0 |
| Investing Cash Flow | $18,800 | $27,500 | $N/A | $1,230 | $2,273 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,200 | 15,100 | N/A | 47,156 | 6,362 |
| Common Stock Repurchased | -103,900 | -45,600 | N/A | -222,014 | -180,124 |
| Other Financing Activity | 2,600 | 1,700 | 0 | 5,109 | 592 |
| Financing Cash Flow | $-81,100 | $-28,800 | $N/A | $-169,749 | $-173,170 |
| Exchange Rate Effect | -2,400 | -700 | N/A | 964 | 392 |
| Beginning Cash Position | 64,800 | 64,800 | N/A | 104,073 | 104,073 |
| End Cash Position | 59,700 | 69,800 | N/A | 85,798 | 71,599 |
| Net Cash Flow | $-5,100 | $5,000 | $N/A | $-18,275 | $-32,474 |
| Free Cash Flow | |||||
| Operating Cash Flow | 59,600 | 7,000 | N/A | 149,280 | 138,031 |
| Capital Expenditure | -17,500 | -11,500 | N/A | -9,653 | -8,098 |
| Free Cash Flow | 42,100 | -4,500 | 0 | 139,627 | 129,933 |